Related Experiment Video

Updated: May 28, 2026

Isolation of Human Atrial Myocytes for Simultaneous Measurements of Ca2+ Transients and Membrane Currents
10:53

Isolation of Human Atrial Myocytes for Simultaneous Measurements of Ca2+ Transients and Membrane Currents

Published on: July 3, 2013

Shaping a new Ca²⁺ conductance to suppress early afterdepolarizations in cardiac myocytes

Roshni V Madhvani1, Yuanfang Xie, Antonios Pantazis

  • 1Division of Molecular Medicine, Department of Anesthesiology, David Geffen School of Medicine at University of California, Los Angeles, CA 90095-7115, USA.

The Journal of Physiology
|October 26, 2011
PubMed

Insights

Sudden cardiac death is linked to early afterdepolarizations (EADs). Modifying the L-type Ca(2+) current (I(Ca,L)) biophysical properties can suppress EADs, offering a potential therapeutic strategy for arrhythmias.

Area of Science:

  • Cardiology
  • Computational Biology
  • Electrophysiology

Background:

  • Sudden cardiac death (SCD) from ventricular fibrillation (VF) is a global health issue.
  • Early afterdepolarizations (EADs) during cardiac action potentials are a common trigger for VF.
  • The L-type Ca(2+) current (I(Ca,L)) plays a critical role in cardiac electrophysiology and EAD formation.

Purpose of the Study:

  • To investigate the dependence of EADs on the biophysical properties of I(Ca,L).
  • To explore how modifying I(Ca,L) properties can suppress EADs and prevent arrhythmias.

Main Methods:

  • A hybrid biological-computational approach was used.
  • EADs were induced in rabbit ventricular myocytes via oxidative stress (H(2)O(2)) or hypokalaemia.
  • The dynamic clamp technique assessed the role of I(Ca,L) by injecting a virtual current with tunable biophysical parameters.

Main Results:

  • Injecting a virtual I(Ca,L) with native properties restored EADs in stressed myocytes.
  • A 5 mV depolarizing shift in activation or hyperpolarizing shift in inactivation of I(Ca,L) abolished EADs.
  • These modifications maintained normal intracellular calcium (Ca(i)) transients.

Conclusions:

  • Modifying the biophysical properties of I(Ca,L) is a promising therapeutic strategy.
  • Targeting I(Ca,L) could suppress EADs and prevent EAD-mediated arrhythmias like VF.
  • This approach offers a novel avenue for treating life-threatening cardiac rhythm disturbances.

More Related Videos

Preparation of Human Myocardial Tissue for Long-Term Cultivation10:58

Preparation of Human Myocardial Tissue for Long-Term Cultivation

Published on: June 2, 2022

Isolation of High Quality Murine Atrial and Ventricular Myocytes for Simultaneous Measurements of Ca2+ Transients and L-Type Calcium Current06:22

Isolation of High Quality Murine Atrial and Ventricular Myocytes for Simultaneous Measurements of Ca2+ Transients and L-Type Calcium Current

Published on: November 3, 2020

Related Concept Videos

Cardiac Action Potential01:30

Cardiac Action Potential

Cardiac action potentials are essential for proper heart function, enabling the rhythmic contractions needed for adequate blood circulation. Nodal cells and Purkinje fibers, specialized for electrical conduction, generate these action potentials.
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory organs,...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Electrophysiology of Normal Cardiac Rhythm01:19

Electrophysiology of Normal Cardiac Rhythm

The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase of...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...